Cart
sales@molnova.com
30-Hydroxygambogic acid
CAS No. 881027-36-7
30-Hydroxygambogic acid( —— )
Catalog No. M31208 CAS No. 881027-36-7
30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Name30-Hydroxygambogic acid
-
NoteResearch use only, not for human use.
-
Brief Description30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.
-
Description30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number881027-36-7
-
Formula Weight644.8
-
Molecular FormulaC38H44O9
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chem Biodivers. 2006 Jan;3(1):101-5.
molnova catalog
related products
-
Elbanizine
Elbanizine showed antiallergic, antiasthmatic, antihistaminic, and spasmolytic activity.
-
AGK7
AGK7 is an inactive control of AGK2, a selective SIRT2 inhibitor that selectively inhibits SIRT3 over SIRT1 and SIRT2 (IC50 = >5 μM, >50 μM and >50 μM for SIRT3, SIRT1, and SIRT2, respectively).
-
6,7-dimethoxy-N-(4-n...
6,7-dimethoxy-N-(4-nitrophenyl)quinazoli
